Epizyme, Inc.
USD1.47
+0.00 (+0.00%)
CEO
Robert Bazemore
IPO Date
2013-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.49
Prev. Close
$1.47
Day Low
$1.47
Day High
$1.50
52W Low
$0.41
52W High
$5.80
| 12 May 2022 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 2 Mar 2022 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Aug 2021 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Aug 2021 | Morgan Stanley | Equal Weight | Underweight | downgrade |
| 7 May 2021 | SVB Leerink | Market Perform | Outperform | upgrade |
| 7 May 2021 | Morgan Stanley | Equal Weight | Equal Weight | maintain |
| 19 Apr 2021 | Morgan Stanley | Equal Weight | Equal Weight | maintain |